Innate Pharma SA Number Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement
Innate Pharma SA (IPHYF) had Number Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement of 106.84 thousand shares as of 2024-06-10, per its 20-F filed 2025-04-30.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:NumberOfOtherEquityInstrumentsExercisedOrVestedInSharebasedPaymentArrangement · last filed 2025-04-30
pure
| Period end | Number Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement 12 month |
|---|---|
| 2019-12-31 | 138265400.00% 20-F · filed 2020-04-24 |
| 2018-12-31 | 114564300.00% 20-F · filed 2020-04-24 |
shares
| Period end | Number Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement |
|---|---|
| 2024-06-10 | 106.84K shares 20-F · filed 2025-04-30 |
| 2022-02-14 | 185.28K shares 20-F · filed 2023-04-06 |
share
| Period end | Number Of Other Equity Instruments Exercised Or Vested In Share-based Payment Arrangement |
|---|---|
| 2024-06-10 | 106.84K share 6-K · filed 2024-09-12 |
| 2023-04-14 | 223.59K share 20-F · filed 2024-04-04 |